StockMarketWire.com - Collagen Solutions has announced its first partnering deal for ChondroMimetic with a South Korean partner, Insung Medical.
Financial terms have not been disclosed.
Jamal Rushdy, CEO of Collagen Solutions, commented:
"We are delighted to announce our first partnering deal with Insung Medical, providing early validation of the global commercial opportunity of ChondroMimetic. Insung Medical's enthusiasm for the opportunity to commercialise ChondroMimetic in South Korea aligns with our strategy to launch the product to address the unmet need for a simple, cost-effective and long-term clinically effective treatment for cartilage defects."
Mr. In Keum Song, Chairman of Insung Medical added:
"I am very delighted to partner with Collagen Solutions for its ChondroMimetic product line. I look forward to a long term positive business relationship with Collagen Solutions as we expand into new technologies".
At 1:23pm: [LON:COS] Collagen Solutions Plc share price was +0.13p at 3p
Story provided by StockMarketWire.com
Shares Magazine

Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events

Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.